Exploring the Antioxidant, Antidiabetic, and Anticancer Potential of Withania somnifera and Withania coagulans: A Comparative Study

Withania somnifera (Ashwagandha) and Withania coagulans (Indian Rennet), two prominent species of the Withania genus (Family: Solanaceae), are well-known for their widespread use in traditional medicine. These plants display various pharmacological properties, including antioxidant, antidiabetic, and anticancer activities. This review compares these pharmacological attributes, aiming at their underlying phytochemical profiles and therapeutic potentials. W. somnifera is rich in withanolides, alkaloids, and flavonoids, contributing to its potent antidiabetic and anticancer effects. Its bioactive compounds modulate various molecular pathways, including oxidative stress, glucose metabolism, and cancer cell proliferation, making it a robust therapeutic candidate. In contrast, W. coagulans exhibits exceptional antioxidant potential due to its high phenolic and flavonoid content, with significant implications for combating oxidative stress-related diseases. Both species demonstrate considerable pharmacological efficacy, with varying degrees of activity, highlighting their corresponding roles in therapeutic applications. This review emphasizes the need for further research to explore their molecular mechanisms, optimize their clinical applications, and evaluate potential synergistic effects. The findings underline the relevance of Withania species as promising candidates for developing novel pharmacological agents that integrate traditional knowledge with modern medicinal approaches. . KEYWORDS :Anticancer, Antidiabetic, Antioxidant, Withania coagulans, Withania somnifera